Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
NCT00113945
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
360
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DRUG:
Cinacalcet
Sponsor
Amgen